Federal Register - March 19, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Rules and Regulations 524.775
Emodepside and praziquantel.
b Sponsor. See No. 058198 in 510.600c of this chapter.
51. In 524.802, revise paragraph b to read as follows:
524.802 Enrofloxacin and silver sulfadiazine otic emulsion.
b Sponsor. See No. 058198 in 510.600c of this chapter.
52. In 524.920, revise paragraphs b1 through 3 to read as follows:
524.920
Fenthion.
b
1 No. 058198 for use of product described in paragraph a1i of this section as in paragraph d1 of this section.
2 No. 058198 for use of product described in paragraph a1ii of this section as in paragraph d2 of this section.
3 No. 058198 for use of products described in paragraph a2 of this section as in paragraph d3 of this section.
53. In 524.955, revise paragraph b to read as follows:
524.955 Florfenicol, terbinafine, and betamethasone acetate otic gel.
b Sponsor. See No. 043264 in 510.600c of this chapter.
54. In 524.957, revise paragraph b to read as follows:
524.957 Florfenicol, terbinafine, and mometasone otic solution.
b Sponsor. See No. 058198 in 510.600c of this chapter.
55. In 524.1140, revise paragraph b to read as follows:
524.1140
jbell on DSKJLSW7X2PROD with RULES
524.1450
PART 558NEW ANIMAL DRUGS FOR
USE IN ANIMAL FEEDS
Moxidectin.
b
1 No. 058198 for use of product described in paragraph a1 of this section as in paragraph d1 of this section; and 2 No. 058198 for use of product described in paragraph a2 of this section as in paragraph d2 of this section.
PART 529CERTAIN OTHER DOSAGE
FORM NEW ANIMAL DRUGS
58. The authority citation for part 529
continues to read as follows:
Authority: 21 U.S.C. 360b.
59. In 529.56, revise paragraph b to read as follows:
529.56
Amikacin.
b Sponsors. See Nos. 054771 and 058198 in 510.600c of this chapter.
60. In 529.1044a, revise paragraph b to read as follows:
529.1044a infusion.
Gentamicin solution for
b Sponsors. See Nos. 000061, 016592, 054628, 054771, 058005, 058198, and 061133 in 510.600c of this chapter.
PART 556TOLERANCES FOR
RESIDUES OF NEW ANIMAL DRUGS
IN FOOD
61. The authority citation for part 556
continues to read as follows:
b Sponsor. See No. 058198 in 510.600c of this chapter.
56. In 524.1146, revise paragraphs b1 through 3 to read as follows:
Authority: 21 U.S.C. 342, 360b, 371.
b
1 Nos. 017030 and 058198 for use of product described in paragraph a1 of this section as in paragraph d1 of this section.
16:22 Mar 18, 2021
Jkt 253001
62. Add 556.168 to read as follows:
556.168
Imidacloprid and moxidectin.
VerDate Sep<11>2014
ii Eggs: 0.1 ppm.
2 Reserved c Related conditions of use. See 558.185 of this chapter.
63. In 556.517, revise paragraph c to read as follows:
Imidacloprid and ivermectin.
524.1146
2 Nos. 017030 and 058198 for use of product described in paragraph a2 of this section as in paragraph d2 of this section.
3 No. 058198 for use of product described in paragraph a2 of this section as in paragraph d3 of this section.
57. In 524.1450, revise paragraphs b1 and 2 to read as follows:
14821
Coumaphos.
a Reserved b Tolerances. The tolerances for coumaphos measured as coumaphos and its oxygen analog, O,O-diethyl O-3chloro-4-methyl-2-oxo-2 H-1benzopyran-7-yl phosphate are:
1 Chickens. i Edible tissues excluding eggs: 1 ppm.
PO 00000
Frm 00015
Fmt 4700
Sfmt 4700
556.517
Poloxalene.
c Related conditions of use. See 520.1840 and 558.464 of this chapter.
64. The authority citation for part 558
continues to read as follows:
Authority: 21 U.S.C. 354, 360b, 360ccc, 360ccc1, 371.
65. In 558.55:
a. Revise paragraph a;
b. Redesignate paragraphs b and d as paragraphs d and e; and c. Add new paragraph b.
The revision and addition read as follows:
558.55
Amprolium.
a Specifications. Type A medicated article containing 25 percent amprolium.
b Sponsor. No. 016592 in 510.600c of this chapter.
66. In 558.58:
a. Revise paragraph b; and b. Redesignate paragraphs c and d as paragraphs d and c.
The revision reads as follows:
558.58
Amprolium and ethopabate.
b Sponsor. See No. 016592 in 510.600c of this chapter.
67. In 558.68, revise paragraph a to read as follows:
558.68
Avilamycin.
a Specifications. Each pound of Type A medicated article contains 45.4
or 90.7 grams of avilamycin.
68. In 558.76:
a. Revise paragraph b;
b. Remove paragraph c; and c. Redesignate paragraphs d and e as paragraphs c and d.
The revision reads as follows:
558.76
Bacitracin methylenedisalicylate.
b Sponsors. See sponsors in 510.600c of this chapter as follows:
1 No. 054771 for use of products in paragraph a1 of this section as in paragraph d of this section.
E:FRFM19MRR1.SGM
19MRR1
